搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
21 天
靶向ROR1的抗体偶联药MK-2140,全部患者病灶消失!
最近的研究发现,一种名为ROR1的蛋白在套细胞淋巴瘤显著高表达,既然有ROR1这个列外的高表达,那就针对ROR1做了一款抗体偶联药VLS-101(也称之为MK ...
腾讯网
1 个月
令人鼓舞的疗效和安全性 基石药业在ASH年会上公布CS5001针对晚期淋巴 ...
智通财经APP获悉,12月9日,基石药业(02616)宣布,公司在第66届美国血液学会(ASH)年会上公布管线2.0重磅产品CS5001(ROR1 ADC)针对淋巴瘤的最新临床数据。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Hughes Fire prompts evacs
Senate advances nomination
Confirmed as CIA director
Judge halts executive order
To visit Central America
Thai same-sex marriage law
100K+ ducks to be killed
Halftime show special guest
Sentenced to over 50 years
Slander conviction upheld
Purdue, Sacklers settlement
Notches closing record
PayPal fined by New York
Face moisturizer recalled
Commandments law in court
Launches bid for governor
Recalling over 270K vehicles
Keys upsets Swiatek
'Bling Empire' star dies
CNN announcing layoffs
New panel to probe Jan. 6
Orders release of secret docs
Announces return to skiing
ACLU sues over deportations
Heat suspend Butler again
Corpse flower draws crowd
Picked as ambassador to EU
ICC targets Taliban leaders
Mulls SC governor’s bid
Houston refinery closure
Jobless claims rise slightly
反馈